Treatment strategies for severe ovarian hyperstimulation.
Bergh
A P
AP
Department of Obstetrics, Gynecology and Reproductive Science, Mount Sinai Medical Center, New York.
Navot
D
D
D000804:Angiotensin II / Q000037:antagonists & inhibitors; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001201:Ascites / Q000209:etiology / Q000601:surgery / Q000628:therapy; D004232:Diuretics / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D009102:Multiple Organ Failure / Q000209:etiology; D016471:Ovarian Hyperstimulation Syndrome / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D010952:Plasma Substitutes / Q000627:therapeutic use; D011677:Punctures; D013396:Suction
D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics; D010952:Plasma Substitutes; D000804:Angiotensin II; D007213:Indomethacin